What Are My Options After a Failed IVF Cycle?
A failed cycle is not a closed door. Here is what the diagnostic workup looks like, what changes can be made to your next protocol, and what to look for in a Los Angeles fertility center when you are ready to try again.
•
SCRC Editorial Team
•
8 min read
A failed IVF cycle is one of the harder experiences in reproductive medicine. The process is demanding in every sense (physically, financially, emotionally) and when it does not result in a pregnancy, the question of what to do next is rarely straightforward. The worst thing you can do is repeat the same cycle without understanding why it failed. The best thing you can do is treat the failure as diagnostic information.
This article explains the most common reasons IVF cycles fail, what a proper post-failure workup looks like, the protocol changes that may improve outcomes in a subsequent cycle, and what patients in Los Angeles should look for when evaluating whether to continue with their current clinic or pursue a second opinion.
WHY IVF CYCLES FAIL
The most common reasons a cycle does not result in pregnancy
IVF failure can occur at multiple points in the process. Identifying where the breakdown happened is the foundation of any meaningful next step. Broadly, failures fall into three categories: embryo quality, uterine receptivity, and protocol design. In practice, these categories overlap, and more than one factor is often at play.
1
Embryo quality and chromosomal status
The majority of IVF failures are attributable to chromosomally abnormal embryos. An embryo that looks morphologically normal under the microscope may still carry a chromosomal error that prevents it from implanting or developing past early stages. This is not a reflection of anything wrong with the IVF process. It is a biological reality of human reproduction: most human embryos, whether conceived naturally or through IVF, are not chromosomally normal. Preimplantation genetic testing for aneuploidy (PGT-A) can identify which embryos are euploid before transfer, which substantially changes the probability of a successful outcome for patients with multiple failed cycles.
Ask your doctor: Has my uterine cavity been fully evaluated? Is an ERA test appropriate in my case?
2
Uterine environment and endometrial receptivity
Even a chromosomally normal embryo requires a receptive uterine environment to implant. Uterine factors that can impair implantation include submucosal fibroids or polyps that protrude into the uterine cavity, intrauterine adhesions (scar tissue), a thin or inadequately developed endometrial lining; hydrosalpinges (fluid-filled fallopian tubes), which have been shown to reduce implantation rates by leaking toxic fluid into the uterine cavity; and a misaligned implantation window. The ERA (Endometrial Receptivity Analysis) test can identify whether a uterine lining is receptive on the day of transfer, or whether the transfer timing needs to be adjusted.
Ask your doctor: Has my uterine cavity been fully evaluated? Is an ERA test appropriate in my case?
3
Stimulation protocol and egg quality
Ovarian stimulation protocols are not one-size-fits-all. Patients with diminished ovarian reserve, PCOS, or prior poor response may need significantly different medication types, dosages, and timing than a standard protocol provides. Under-stimulation produces too few eggs; over-stimulation can impair egg quality and uterine receptivity. The choice of trigger shot, the timing of the retrieval, and the composition of the stimulation protocol all affect the quality of the eggs that reach the lab. A clinic that uses the same protocol across all patients regardless of prior response data is not optimizing for you.
Ask your doctor: Looking at my last cycle’s response data, what would you change about my stimulation protocol?
4
Sperm factors
Sperm quality affects fertilization rates and embryo development, but is often underexamined after a failed cycle. Standard semen analysis measures concentration, motility, and morphology, but does not assess sperm DNA fragmentation, a measure of structural damage to sperm genetic material associated with poor embryo development and increased miscarriage risk. DNA fragmentation testing is not routinely ordered but is worth evaluating after multiple failures, particularly if fertilization rates were low or embryo development was poor.
Ask your doctor: Has sperm DNA fragmentation been tested? If fragmentation is elevated, what are the options?
5
Lab environment and embryology quality
Lab quality is one of the most significant but least visible variables in IVF outcomes. Differences in incubator technology, culture media, air quality, and embryologist skill all affect embryo development. Patients who have cycled at clinics with limited volume or older equipment may see different results at a higher-volume center with modern infrastructure. If a failed cycle involves low fertilization rates, poor blastocyst conversion, or unexpected embryo arrest, the lab environment is a reasonable area of inquiry.
Ask your doctor: What were my fertilization and blastocyst conversion rates compared to your lab’s benchmarks?
THE POST-FAILURE WORKUP
What a thorough evaluation looks like
Before attempting another cycle, a comprehensive review should cover every area where the prior cycle could have been stronger. The specific tests ordered will depend on your history, but the following are the most commonly indicated.
UTERINE EVALUATION
A saline infusion sonogram (SIS) or office hysteroscopy can identify polyps, fibroids, and adhesions that may not have been visible on standard ultrasound. If the uterine cavity has not been formally evaluated since the failed cycle, this is a first-line step. Hydrosalpinges, if present, should be addressed before any subsequent transfer, the evidence for removing or occluding fluid-filled tubes before IVF is strong.
ENDOMETRIAL RECEPTIVITY ANALYSIS (ERA)
The ERA test involves a mock cycle in which the endometrial lining is prepared exactly as it would be for a frozen embryo transfer, and a biopsy is taken at the standard transfer window. The biopsy is analyzed to determine whether the endometrium is receptive, pre-receptive, or post-receptive at that point. Studies suggest that 20–30% of patients who fail repeated transfers have a displaced implantation window. For those patients, adjusting the transfer timing to match their personal receptivity window can significantly improve outcomes.
PGT-A AND EMBRYO RE-EVALUATION
If prior cycles did not include PGT-A, testing embryos from the next retrieval cycle is a meaningful change for patients with multiple failures. For patients who already used PGT-A and transferred euploid embryos without success, the workup shifts toward uterine and implantation factors rather than embryo quality.
SPERM DNA FRAGMENTATION
Testing should be considered if prior cycles showed low fertilization, poor embryo quality, or high rates of embryo arrest. If fragmentation is elevated, options include antioxidant supplementation, testicular sperm extraction (TESE) rather than ejaculated sperm, or sperm selection techniques designed to identify lower-fragmentation sperm for ICSI.
WHAT CAN CHANGE IN THE NEXT CYCLE
Protocol modifications worth discussing with your doctor
A failed cycle should change something. The specific modifications depend on where the prior cycle underperformed, but the following are the most commonly considered adjustments.
Stimulation protocol adjustment. Switching protocols, changing medication dosages, or modifying the trigger strategy can all affect the number and quality of eggs retrieved. Patients with poor prior response may benefit from a modified minimal stimulation approach, or from adjuncts such as growth hormone or DHEA supplementation, though evidence for adjuncts varies.
Frozen embryo transfer (FET) instead of fresh transfer. High stimulation can compromise uterine receptivity in fresh cycles. A frozen transfer in a separate, unstimulated cycle allows the uterus to prepare without the hormonal effects of stimulation. Many clinics now prefer FET for most patients, particularly those who did not respond ideally to stimulation.
Progesterone supplementation adjustments. There is evidence that some patients do not absorb vaginal progesterone effectively. Switching to injectable progesterone, adding oral progesterone, or monitoring progesterone levels before and after transfer can identify and correct luteal phase insufficiency, a factor that is underdiagnosed in patients with repeated implantation failure.
Transfer timing based on ERA results. If ERA indicates a displaced receptivity window, the transfer is moved, typically by 12 to 24 hours in either direction. This is a low-cost, high-signal intervention for patients who have already confirmed good embryo quality.
Single embryo transfer (eSET). Transferring more than one embryo does not meaningfully improve the odds of a live birth and substantially increases the risk of multiples. If prior cycles used double embryo transfers, switching to eSET with a chromosomally tested embryo is generally the recommended approach.
SEEKING A SECOND OPINION IN LOS ANGELES
What to look for when evaluating a fertility center after prior failures
Los Angeles has a high concentration of fertility clinics. Not all of them approach failed cycles the same way, and the quality of the post-failure workup varies significantly. These are the factors that matter most when evaluating where to continue care.
- The clinic treats your prior cycle records as essential. A physician who is willing to see you for a second opinion without your prior records is not going to be able to tell you anything meaningful.
- The physician reviews your prior stimulation data specifically, your AMH, antral follicle count, peak estradiol, number of eggs retrieved, fertilization rate, blastocyst conversion rate, and embryo grading.
- The clinic has a clear protocol for ordering diagnostic workup before recommending another cycle, including uterine evaluation, endometrial receptivity testing when indicated, and sperm DNA fragmentation when relevant.
- The embryology lab operates at a volume that supports daily ICSI, biopsy, and vitrification. Ask about fertilization rates and blastocyst conversion rates; confident labs answer with numbers.
- The clinic does not pressure you toward another cycle before the prior one has been properly analyzed. A physician who recommends repeating the same protocol without changes is not working from your data.
A NOTE ON THE EMOTIONAL DIMENSION
What failed cycles do to patients and what good clinics understand
The emotional weight of IVF failure is real and significant. Grief, frustration, and exhaustion after a failed cycle are legitimate responses, not obstacles to overcome before the next clinical conversation. Patients who have been through multiple failures often carry a combination of hope and protective skepticism into subsequent consultations, which is entirely reasonable.
A good fertility clinic understands this. The consultation after a failure should include time to process what happened and ask questions, not just a pivot to what comes next. If you feel rushed through the diagnostic conversation, or if your questions about prior cycle outcomes are dismissed, that is worth weighing when deciding whether to continue at that clinic.
COMMON QUESTIONS
Frequently asked questions
There is no universal threshold. The right number depends on your age, your diagnosis, the quality of the embryos being transferred, and what the diagnostic workup reveals after each failure. In general, three or more failed transfers with good-quality embryos is the point at which most specialists recommend a comprehensive workup if one has not already been done. The question is not how many to try, but whether the underlying factors have been fully evaluated.
A second opinion is reasonable after any failed cycle if you have questions your current physician has not answered. It is particularly warranted if your clinic is recommending repeating the same protocol without changes, if the post-failure consultation was brief or did not include a detailed review of your cycle data, or if you want an independent assessment before investing in another retrieval or transfer.
No. PGT-A identifies chromosomally normal embryos, which improves implantation rates compared to untested embryos. But chromosomal normalcy is necessary, not sufficient. A euploid embryo still requires a receptive uterine environment and appropriate hormonal support to implant successfully. Patients who transfer PGT-A-normal embryos and still do not achieve pregnancy have a workup path that focuses on implantation factors rather than embryo quality.
Recurrent implantation failure (RIF) is generally defined as failure to achieve a clinical pregnancy after three or more embryo transfers of good-quality embryos. It is distinct from recurrent pregnancy loss. RIF typically prompts a workup focused on uterine factors, endometrial receptivity, immune or thrombophilic factors, and sperm quality. Some interventions commonly offered for RIF have limited evidence; a specialist with experience in RIF can help you distinguish evidence-based options from those with less support.
Yes. Clinic-level SART data requires careful interpretation — clinics that treat more complex cases may show lower headline rates than clinics that selectively treat low-risk patients. More useful than headline rates are cycle-specific metrics: fertilization rates, blastocyst conversion rates, and implantation rates per embryo transferred. A consultation at a high-volume, well-equipped center gives you a direct basis for comparison.
Bring your prior cycle records, including your baseline bloodwork (AMH, FSH, antral follicle count), stimulation chart, egg retrieval summary (number retrieved, number mature, fertilization rate), embryo development report (day 5 grading, PGT-A results if tested), and transfer records. The more complete your records, the more useful the consultation will be.
Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. IVF outcomes depend on many individual factors. Consult a board-certified Reproductive Endocrinologist for a personalized evaluation.
